These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 33091447)
21. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis. Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745 [TBL] [Abstract][Full Text] [Related]
22. Chemokine ligand 20 (CCL20) expression increases with NAFLD stage and hepatic stellate cell activation and is regulated by miR-590-5p. Hanson A; Piras IS; Wilhelmsen D; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK Cytokine; 2019 Nov; 123():154789. PubMed ID: 31352173 [TBL] [Abstract][Full Text] [Related]
23. Ubiquitination of cytoplasmic HMGB1 by RNF186 regulates hepatic lipophagy in non-alcoholic fatty liver disease. Du J; Ji X; Xu B; Du Q; Li Y; Zhou B; Liu X; Xu Z; Jiang Y; Kou B; Li Z; Cui C; Lin J Metabolism; 2024 Mar; 152():155769. PubMed ID: 38158076 [TBL] [Abstract][Full Text] [Related]
24. Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction. Zhang X; Lin Y; Lin S; Li C; Gao J; Feng Z; Wang J; Zhang J; Zhang H; Zhang Y; Chen X; Chen S; Xu C; Li Y; Yu C; Zeng H Hepatol Int; 2020 Sep; 14(5):828-841. PubMed ID: 32607732 [TBL] [Abstract][Full Text] [Related]
25. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition. Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165 [TBL] [Abstract][Full Text] [Related]
26. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356 [TBL] [Abstract][Full Text] [Related]
27. [Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression]. Kong LB; Ren WG; Mi HM; Zhao SX; Zhang YG; Nan YM Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):207-12. PubMed ID: 23967743 [TBL] [Abstract][Full Text] [Related]
29. Role of High-Mobility Group Box-1 in Liver Pathogenesis. Khambu B; Yan S; Huda N; Yin XM Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731454 [TBL] [Abstract][Full Text] [Related]
30. Lipocalin 2 induces neuroinflammation and blood-brain barrier dysfunction through liver-brain axis in murine model of nonalcoholic steatohepatitis. Mondal A; Bose D; Saha P; Sarkar S; Seth R; Kimono D; Albadrani M; Nagarkatti M; Nagarkatti P; Chatterjee S J Neuroinflammation; 2020 Jul; 17(1):201. PubMed ID: 32622362 [TBL] [Abstract][Full Text] [Related]
31. Role of Osteopontin in Liver Diseases. Wen Y; Jeong S; Xia Q; Kong X Int J Biol Sci; 2016; 12(9):1121-8. PubMed ID: 27570486 [TBL] [Abstract][Full Text] [Related]
32. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. Li X; Wang Z; Klaunig JE Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707 [TBL] [Abstract][Full Text] [Related]
33. Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell. He Q; Xia X; Yao K; Zeng J; Wang W; Wu Q; Tang R; Zou X Life Sci; 2019 Dec; 239():117010. PubMed ID: 31672578 [TBL] [Abstract][Full Text] [Related]
34. Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease. Xu Z; Xi F; Deng X; Ni Y; Pu C; Wang D; Lou W; Zeng X; Su N; Chen C; Zeng Z; Deng L; Jiang M J Clin Transl Hepatol; 2023 Apr; 11(2):273-283. PubMed ID: 36643029 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease. Liang D; Chen H; Zhao L; Zhang W; Hu J; Liu Z; Zhong P; Wang W; Wang J; Liang G Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):133-142. PubMed ID: 29038049 [TBL] [Abstract][Full Text] [Related]
36. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. Li BH; He FP; Yang X; Chen YW; Fan JG Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593 [TBL] [Abstract][Full Text] [Related]
37. γ-Mangostin alleviates liver fibrosis through Sirtuin 3-superoxide-high mobility group box 1 signaling axis. Wang A; Zhou F; Li D; Lu JJ; Wang Y; Lin L Toxicol Appl Pharmacol; 2019 Jan; 363():142-153. PubMed ID: 30502394 [TBL] [Abstract][Full Text] [Related]
38. Osteopontin - A potential biomarker of advanced liver disease. Bruha R; Vitek L; Smid V Ann Hepatol; 2020; 19(4):344-352. PubMed ID: 32005637 [TBL] [Abstract][Full Text] [Related]
39. STUB1 increases adiponectin expression by inducing ubiquitination and degradation of NR2F2, thereby reducing hepatic stellate cell activation and alleviating non-alcoholic fatty liver disease. Mao Z; Zhao J; Cui F; Li Z; Cao J; Zhou J; Hou M; Qian Z Tissue Cell; 2024 Jun; 88():102345. PubMed ID: 38471267 [TBL] [Abstract][Full Text] [Related]
40. Role of growth factor receptor-bound 2 in CCl Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]